NASOFAN spray nasal 50 mcg 120 dos

7680581690048 CH-58169 R01AD08 12.02.3.
NASOFAN spray nasal 50 mcg 120 dos
NASOFAN spray nasal 50 mcg 120 dos
NASOFAN spray nasal 50 mcg 120 dos
1 / 3
google

Details

Product number
5816901
CPT
-
Packaging group
120
Unit
Inhalationen
Composition
fluticasoni propionas 50 µg, conserv.: alcohol phenylethylicus, benzalkonii chloridum, excipiens ad suspensionem pro dosi.

Articles (1)

Nasofan, Nasenspray
Nasenspray
120
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/08/2025
Patient information leaflet
Français
01/08/2025
Patient information leaflet
Italien
01/08/2025
Professional SmPC
Allemand
01/08/2025
Professional SmPC
Français
01/08/2025
Professional SmPC
Italien
01/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Konservierungsstoff (Conservateur)
(N/A)
40.0 UG Substance Konservierungsstoff (Conservateur)
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 31.25
Specialties list
Yes
Generic
Yes
SL addition date: 01/03/2009

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
58169
Drug name
Nasofan, Nasenspray, Suspension
Galenic form
NASS
ATC Code
R01AD08
Authorization status
Z
Dispensation category
B
First authorization
02/02/2009
Authorization expiration date
31/12/9999
IT number
12.02.3.
Domain
Human medicine
Field of application
Saisonale Rhinitis und perenniale Rhinitis

Packaging details

Description (FR)
NASOFAN spray nasal 50 mcg 120 dos
Description (DE)
NASOFAN Nasenspray 50 mcg 120 Dos
Market launch
02/02/2009
Narcotic (BTM)
No

Other packaging sizes